| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.914 | 0.003 | 0.921 | Caspase 9 stimulant | 0.921 0.002 CID_5318041 | CID_5318041 | |
| 0.898 | 0.003 | 0.904 | Aldehyde oxidase inhibitor | 0.904 0.003 CID_5318041 | CID_5318041 | |
| 0.862 | 0.009 | 0.872 | Apoptosis agonist | 0.872 0.009 CID_5318041 | CID_5318041 | |
| 0.813 | 0.004 | 0.839 | Free radical scavenger | 0.839 0.004 CID_5318041 | CID_5318041 | |
| 0.786 | 0.004 | 0.813 | Antioxidant | 0.813 0.004 CID_5318041 | CID_5318041 | |
| 0.778 | 0.004 | 0.787 | Caspase 3 stimulant | 0.787 0.004 CID_5318041 | CID_5318041 | |
| 0.734 | 0.004 | 0.761 | Histamine release inhibitor | 0.761 0.004 CID_5318041 | CID_5318041 | |
| 0.726 | 0.002 | 0.756 | Cystathionine beta-synthase inhibitor | 0.756 0.002 CID_5318041 | CID_5318041 | |
| 0.727 | 0.004 | 0.788 | Tubulin antagonist | 0.788 0.004 CID_5318041 | CID_5318041 | |
| 0.725 | 0.003 | 0.725 | Breast cancer-resistant protein inhibitor | 0.721 0.004 CID_5318041 | ||
| 0.724 | 0.006 | 0.765 | 12-Lipoxygenase inhibitor | 0.765 0.005 CID_5318041 | CID_5318041 | |
| 0.696 | 0.005 | 0.742 | Amyloid beta aggregation inhibitor | 0.742 0.005 CID_5318041 | CID_5318041 | |
| 0.679 | 0.005 | 0.679 | 5 Hydroxytryptamine release inhibitor | 0.636 0.007 CID_5318041 | ||
| 0.693 | 0.021 | 0.709 | Transcription factor NF kappa B inhibitor | 0.709 0.019 CID_5318041 | CID_5318041 | |
| 0.666 | 0.004 | 0.666 | GABA C receptor rho-3 antagonist | 0.603 0.007 CID_5318041 | ||
| 0.654 | 0.004 | 0.657 | P-glycoprotein inhibitor | 0.657 0.004 CID_5318041 | CID_5318041 | |
| 0.648 | 0.004 | 0.655 | Peroxidase inhibitor | 0.655 0.004 CID_5318041 | CID_5318041 | |
| 0.641 | 0.003 | 0.663 | NADPH oxidase inhibitor | 0.663 0.003 CID_5318041 | CID_5318041 | |
| 0.635 | 0.008 | 0.696 | Lipoxygenase inhibitor | 0.696 0.005 CID_5318041 | CID_5318041 | |
| 0.663 | 0.041 | 0.685 | Alpha-glucosidase inhibitor | 0.685 0.036 CID_5318041 | CID_5318041 | |
| 0.619 | 0.007 | 0.631 | Vasodilator, coronary | 0.631 0.006 CID_5318041 | CID_5318041 | |
| 0.624 | 0.02 | 0.671 | 15-Lipoxygenase inhibitor | 0.671 0.015 CID_5318041 | CID_5318041 | |
| 0.588 | 0.007 | 0.635 | Superoxide dismutase inhibitor | 0.635 0.005 CID_5318041 | CID_5318041 | |
| 0.573 | 0.005 | 0.581 | Monophenol monooxygenase inhibitor | 0.581 0.005 CID_5318041 | CID_5318041 | |
| 0.575 | 0.015 | 0.594 | Spasmolytic | 0.594 0.013 CID_5318041 | CID_5318041 | |
| 0.558 | 0.009 | 0.604 | Antimitotic | 0.604 0.007 CID_5318041 | CID_5318041 | |
| 0.536 | 0.005 | 0.556 | MAO A inhibitor | 0.556 0.005 CID_5318041 | CID_5318041 | |
| 0.532 | 0.005 | 0.547 | Amylase inhibitor | 0.547 0.005 CID_5318041 | CID_5318041 | |
| 0.543 | 0.02 | 0.551 | Aryl hydrocarbon receptor agonist | 0.551 0.019 CID_5318041 | CID_5318041 | |
| 0.575 | 0.06 | 0.617 | Antiinflammatory | 0.617 0.049 CID_5318041 | CID_5318041 | |
| 0.515 | 0.005 | 0.531 | Acetylcholinesterase inhibitor | 0.531 0.005 CID_5318041 | CID_5318041 | |
| 0.51 | 0.006 | 0.52 | Melanin inhibitor | 0.52 0.006 CID_5318041 | CID_5318041 | |
| 0.505 | 0.004 | 0.535 | Xanthine oxidase inhibitor | 0.535 0.003 CID_5318041 | CID_5318041 | |
| 0.512 | 0.015 | 0.557 | Antiamyloidogenic | 0.557 0.011 CID_5318041 | CID_5318041 | |
| 0.501 | 0.007 | 0.515 | MAO inhibitor | 0.515 0.007 CID_5318041 | CID_5318041 | |
| 0.501 | 0.014 | 0.54 | DNA damaging | 0.54 0.011 CID_5318041 | CID_5318041 | |
| 0.49 | 0.004 | 0.594 | Alpha tubulin antagonist | 0.594 0.003 CID_5318041 | CID_5318041 | |
| 0.501 | 0.02 | 0.516 | Apoptosis antagonist | 0.516 0.018 CID_5318041 | CID_5318041 | |
| 0.495 | 0.016 | 0.519 | Nitric oxide antagonist | 0.519 0.014 CID_5318041 | CID_5318041 | |
| 0.474 | 0.004 | 0.477 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.477 0.004 CID_5318041 | CID_5318041 | |
| 0.481 | 0.012 | 0.493 | RNA-directed DNA polymerase inhibitor | 0.493 0.011 CID_5318041 | CID_5318041 | |
| 0.475 | 0.008 | 0.488 | Hepatoprotectant | 0.488 0.008 CID_5318041 | CID_5318041 | |
| 0.481 | 0.016 | 0.513 | Hypoxia-inducible factor 1 alpha inhibitor | 0.513 0.013 CID_5318041 | CID_5318041 | |
| 0.467 | 0.003 | 0.497 | Carbonic anhydrase XIII inhibitor | 0.497 0.003 CID_5318041 | CID_5318041 | |
| 0.475 | 0.014 | 0.495 | Vasodilator | 0.495 0.012 CID_5318041 | CID_5318041 | |
| 0.46 | 0.005 | 0.466 | Protein kinase stimulant | 0.466 0.005 CID_5318041 | CID_5318041 | |
| 0.465 | 0.018 | 0.507 | Tumour necrosis factor alpha release inhibitor | 0.507 0.013 CID_5318041 | CID_5318041 | |
| 0.48 | 0.036 | 0.48 | Calcium channel L-type activator | 0.416 0.071 CID_5318041 | ||
| 0.442 | 0.003 | 0.457 | Creatine kinase inhibitor | 0.457 0.002 CID_5318041 | CID_5318041 | |
| 0.446 | 0.007 | 0.474 | Lipid peroxidase inhibitor | 0.474 0.006 CID_5318041 | CID_5318041 | |
| 0.445 | 0.021 | 0.445 | Hypoglycemic | 0.443 0.021 CID_5318041 | ||
| 0.425 | 0.004 | 0.514 | Beta tubulin antagonist | 0.514 0.004 CID_5318041 | CID_5318041 | |
| 0.424 | 0.009 | 0.442 | Cholinergic | 0.442 0.008 CID_5318041 | CID_5318041 | |
| 0.425 | 0.01 | 0.474 | 5 Hydroxytryptamine uptake stimulant | 0.474 0.005 CID_5318041 | CID_5318041 | |
| 0.417 | 0.005 | 0.429 | Interleukin 4 antagonist | 0.429 0.005 CID_5318041 | CID_5318041 | |
| 0.461 | 0.051 | 0.483 | Prostaglandin dehydrogenase inhibitor | 0.483 0.045 CID_5318041 | CID_5318041 | |
| 0.395 | 0.004 | 0.395 | Aldose reductase inhibitor | 0.392 0.004 CID_5318041 | ||
| 0.404 | 0.019 | 0.433 | Pyruvate kinase inhibitor | 0.433 0.016 CID_5318041 | CID_5318041 | |
| 0.393 | 0.01 | 0.399 | Topoisomerase II inhibitor | 0.399 0.01 CID_5318041 | CID_5318041 | |
| 0.385 | 0.004 | 0.385 | GABA C receptor rho-2 antagonist | 0.332 0.004 CID_5318041 | ||
| 0.378 | 0.017 | 0.387 | Dual specificity phosphatase inhibitor | 0.387 0.016 CID_5318041 | CID_5318041 | |
| 0.357 | 0.003 | 0.357 | Multidrug resistance-associated protein 1 inhibitor | 0.355 0.003 CID_5318041 | ||
| 0.371 | 0.017 | 0.381 | Dual specificity phosphatase 3 inhibitor | 0.381 0.016 CID_5318041 | CID_5318041 | |
| 0.356 | 0.007 | 0.388 | Alkaline phosphatase inhibitor | 0.388 0.006 CID_5318041 | CID_5318041 | |
| 0.354 | 0.005 | 0.354 | Topoisomerase II alpha inhibitor | 0.346 0.005 CID_5318041 | ||
| 0.409 | 0.073 | 0.414 | Antibacterial | 0.414 0.071 CID_5318041 | CID_5318041 | |
| 0.34 | 0.005 | 0.356 | Nitric-oxide synthase stimulant | 0.356 0.005 CID_5318041 | CID_5318041 | |
| 0.335 | 0.004 | 0.335 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.323 0.004 CID_5318041 | ||
| 0.332 | 0.009 | 0.352 | Butyrylcholinesterase inhibitor | 0.352 0.008 CID_5318041 | CID_5318041 | |
| 0.323 | 0.005 | 0.323 | Histidine decarboxylase inhibitor | 0.319 0.005 CID_5318041 | ||
| 0.323 | 0.009 | 0.366 | 5-Lipoxygenase inhibitor | 0.366 0.006 CID_5318041 | CID_5318041 | |
| 0.317 | 0.005 | 0.329 | Beta glucuronidase inhibitor | 0.329 0.005 CID_5318041 | CID_5318041 | |
| 0.315 | 0.005 | 0.321 | Carbonic anhydrase VI inhibitor | 0.321 0.005 CID_5318041 | CID_5318041 | |
| 0.31 | 0.012 | 0.312 | MAO B inhibitor | 0.312 0.012 CID_5318041 | CID_5318041 | |
| 0.314 | 0.016 | 0.325 | NOS3 expression enhancer | 0.325 0.014 CID_5318041 | CID_5318041 | |
| 0.311 | 0.016 | 0.343 | Tumour necrosis factor antagonist | 0.343 0.011 CID_5318041 | CID_5318041 | |
| 0.341 | 0.053 | 0.406 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.406 0.037 CID_5318041 | CID_5318041 | |
| 0.287 | 0.009 | 0.287 | Carbonic anhydrase XV inhibitor | 0.281 0.009 CID_5318041 | ||
| 0.331 | 0.053 | 0.331 | Sodium/bile acid cotransporter inhibitor | 0.316 0.065 CID_5318041 | ||
| 0.333 | 0.061 | 0.333 | 5 Hydroxytryptamine release stimulant | 0.276 0.078 CID_5318041 | ||
| 0.276 | 0.007 | 0.28 | Carbonic anhydrase III inhibitor | 0.28 0.006 CID_5318041 | CID_5318041 | |
| 0.273 | 0.006 | 0.273 | Estrogen receptor beta antagonist | 0.191 0.01 CID_5318041 | ||
| 0.298 | 0.035 | 0.312 | Platelet adhesion inhibitor | 0.312 0.03 CID_5318041 | CID_5318041 | |
| 0.293 | 0.036 | 0.293 | Tyrosine 3 hydroxylase inhibitor | 0.275 0.048 CID_5318041 | ||
| 0.284 | 0.032 | 0.314 | Non-steroidal antiinflammatory agent | 0.314 0.025 CID_5318041 | CID_5318041 | |
| 0.256 | 0.005 | 0.256 | Histone deacetylase SIRT1 stimulant | 0.228 0.005 CID_5318041 | ||
| 0.256 | 0.005 | 0.256 | Histone deacetylase stimulant | 0.228 0.005 CID_5318041 | ||
| 0.304 | 0.054 | 0.304 | Transcription factor STAT inhibitor | 0.297 0.058 CID_5318041 | ||
| 0.271 | 0.025 | 0.282 | Protein-tyrosine phosphatase inhibitor | 0.282 0.023 CID_5318041 | CID_5318041 | |
| 0.249 | 0.004 | 0.279 | Xanthine dehydrogenase inhibitor | 0.279 0.003 CID_5318041 | CID_5318041 | |
| 0.253 | 0.008 | 0.253 | Estrogen antagonist | 0.191 0.014 CID_5318041 | ||
| 0.261 | 0.018 | 0.342 | M18 aspartyl aminopeptidase inhibitor | 0.342 0.008 CID_5318041 | CID_5318041 | |
| 0.257 | 0.017 | 0.257 | Aldehyde dehydrogenase inhibitor | 0.185 0.032 CID_5318041 | ||
| 0.249 | 0.009 | 0.285 | Telomerase inhibitor | 0.285 0.007 CID_5318041 | CID_5318041 | |
| 0.243 | 0.008 | 0.258 | Protein kinase C zeta inhibitor | 0.258 0.007 CID_5318041 | CID_5318041 | |
| 0.258 | 0.023 | 0.258 | Bone formation stimulant | 0.23 0.029 CID_5318041 | ||
| 0.27 | 0.038 | 0.301 | DNA methyltransferase I inhibitor | 0.301 0.026 CID_5318041 | CID_5318041 | |
| 0.283 | 0.055 | 0.288 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.288 0.053 CID_5318041 | CID_5318041 | |
| 0.236 | 0.01 | 0.236 | Mediator release inhibitor | 0.219 0.012 CID_5318041 | ||
| 0.243 | 0.017 | 0.273 | Chelator | 0.273 0.013 CID_5318041 | CID_5318041 | |
| 0.36 | 0.135 | 0.398 | DNA polymerase beta inhibitor | 0.398 0.12 CID_5318041 | CID_5318041 | |
| 0.255 | 0.031 | 0.259 | Amyloid beta precursor protein antagonist | 0.259 0.03 CID_5318041 | CID_5318041 | |
| 0.304 | 0.085 | 0.313 | Antithrombotic | 0.313 0.08 CID_5318041 | CID_5318041 | |
| 0.222 | 0.005 | 0.222 | GABA C receptor rho-1 antagonist | 0.188 0.01 CID_5318041 | ||
| 0.239 | 0.023 | 0.242 | Cyclooxygenase 1 inhibitor | 0.242 0.023 CID_5318041 | CID_5318041 | |
| 0.242 | 0.028 | 0.246 | Cyclooxygenase inhibitor | 0.246 0.027 CID_5318041 | CID_5318041 | |
| 0.231 | 0.02 | 0.245 | Topoisomerase I inhibitor | 0.245 0.018 CID_5318041 | CID_5318041 | |
| 0.232 | 0.024 | 0.254 | Hemostatic | 0.254 0.021 CID_5318041 | CID_5318041 | |
| 0.221 | 0.013 | 0.228 | Cyclooxygenase 3 inhibitor | 0.228 0.012 CID_5318041 | CID_5318041 | |
| 0.299 | 0.093 | 0.299 | Calcium channel activator | 0.267 0.127 CID_5318041 | ||
| 0.219 | 0.013 | 0.219 | CF transmembrane conductance regulator agonist | 0.179 0.037 CID_5318041 | ||
| 0.265 | 0.063 | 0.269 | Angiogenesis stimulant | 0.269 0.061 CID_5318041 | CID_5318041 | |
| 0.223 | 0.023 | 0.232 | Protein-tyrosine phosphatase 1B inhibitor | 0.232 0.02 CID_5318041 | CID_5318041 | |
| 0.212 | 0.012 | 0.223 | Uric acid excretion stimulant | 0.223 0.01 CID_5318041 | CID_5318041 | |
| 0.229 | 0.031 | 0.256 | Succinate dehydrogenase inhibitor | 0.256 0.02 CID_5318041 | CID_5318041 | |
| 0.204 | 0.005 | 0.205 | Heat shock protein 70 antagonist | 0.205 0.005 CID_5318041 | CID_5318041 | |
| 0.239 | 0.045 | 0.252 | Neurotrophic factor enhancer | 0.252 0.037 CID_5318041 | CID_5318041 | |
| 0.2 | 0.009 | 0.257 | HIV-1 integrase (Strand Transfer) inhibitor | 0.257 0.006 CID_5318041 | CID_5318041 | |
| 0.192 | 0.005 | 0.2 | Carbonic anhydrase VII inhibitor | 0.2 0.005 CID_5318041 | CID_5318041 | |
| 0.207 | 0.02 | 0.222 | Toll-Like receptor 2 antagonist | 0.222 0.015 CID_5318041 | CID_5318041 | |
| 0.194 | 0.009 | 0.205 | Electron transport complex I inhibitor | 0.205 0.008 CID_5318041 | CID_5318041 | |
| 0.195 | 0.01 | 0.269 | HIV-1 integrase (3'-Processing) inhibitor | 0.269 0.005 CID_5318041 | CID_5318041 | |
| 0.247 | 0.063 | 0.247 | Interleukin antagonist | 0.204 0.082 CID_5318041 | ||
| 0.213 | 0.03 | 0.213 | Insulin secretagoues | 0.212 0.03 CID_5318041 | ||
| 0.196 | 0.014 | 0.196 | GABA C receptor antagonist | 0.163 0.024 CID_5318041 | ||
| 0.19 | 0.009 | 0.19 | Estrogen agonist | 0.132 0.013 CID_5318041 | ||
| 0.252 | 0.071 | 0.257 | Dyrk kinase inhibitor | 0.257 0.069 CID_5318041 | CID_5318041 | |
| 0.191 | 0.011 | 0.195 | Urease inhibitor | 0.195 0.011 CID_5318041 | CID_5318041 | |
| 0.193 | 0.014 | 0.193 | Photosensitizer | 0.167 0.022 CID_5318041 | ||
| 0.188 | 0.009 | 0.193 | Aromatase inhibitor | 0.193 0.009 CID_5318041 | CID_5318041 | |
| 0.206 | 0.029 | 0.21 | Cyclooxygenase 2 inhibitor | 0.21 0.028 CID_5318041 | CID_5318041 | |
| 0.181 | 0.005 | 0.186 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.186 0.004 CID_5318041 | CID_5318041 | |
| 0.209 | 0.034 | 0.209 | Heat shock protein 90 antagonist | 0.201 0.037 CID_5318041 | ||
| 0.325 | 0.15 | 0.364 | DNA directed DNA polymerase inhibitor | 0.364 0.132 CID_5318041 | CID_5318041 | |
| 0.188 | 0.013 | 0.188 | Papain-like protease (SARS coronavirus) inhibitor | 0.182 0.015 CID_5318041 | ||
| 0.183 | 0.01 | 0.196 | DOPA decarboxylase inhibitor | 0.196 0.007 CID_5318041 | CID_5318041 | |
| 0.23 | 0.06 | 0.263 | DNA methylase inhibitor | 0.263 0.041 CID_5318041 | CID_5318041 | |
| 0.177 | 0.009 | 0.177 | Cyclin B3 inhibitor | 0.173 0.009 CID_5318041 | ||
| 0.177 | 0.01 | 0.189 | Macrophage migration inhibitory factor inhibitor | 0.189 0.009 CID_5318041 | CID_5318041 | |
| 0.18 | 0.014 | 0.181 | AMP-activated protein kinase stimulant | 0.181 0.014 CID_5318041 | CID_5318041 | |
| 0.226 | 0.061 | 0.226 | Anesthetic general | 0.203 0.073 CID_5318041 | ||
| 0.169 | 0.004 | 0.178 | D-Ala-D-Ala ligase inhibitor | 0.178 0.004 CID_5318041 | CID_5318041 | |
| 0.177 | 0.014 | 0.177 | DNA repair enzyme inhibitor | 0.176 0.015 CID_5318041 | ||
| 0.234 | 0.072 | 0.276 | Cyclic AMP phosphodiesterase inhibitor | 0.276 0.052 CID_5318041 | CID_5318041 | |
| 0.196 | 0.037 | 0.209 | Arachidonic acid antagonist | 0.209 0.025 CID_5318041 | CID_5318041 | |
| 0.165 | 0.007 | 0.165 | Thioredoxin reductase inhibitor | 0.158 0.008 CID_5318041 | ||
| 0.162 | 0.004 | 0.162 | Potassium channel Kv1.3 blocker | 0.137 0.005 CID_5318041 | ||
| 0.162 | 0.01 | 0.162 | Estrogen receptor alpha antagonist | 0.159 0.01 CID_5318041 | ||
| 0.267 | 0.115 | 0.29 | Vasodilator, peripheral | 0.29 0.102 CID_5318041 | CID_5318041 | |
| 0.183 | 0.032 | 0.184 | Alkylator | 0.184 0.031 CID_5318041 | CID_5318041 | |
| 0.25 | 0.103 | 0.25 | Streptokinase A inhibitor | 0.225 0.118 CID_5318041 | ||
| 0.246 | 0.1 | 0.246 | Insulysin inhibitor | 0.237 0.109 CID_5318041 | ||
| 0.155 | 0.01 | 0.155 | Interleukin 5 antagonist | 0.136 0.015 CID_5318041 | ||
| 0.19 | 0.047 | 0.2 | Interleukin 6 antagonist | 0.2 0.041 CID_5318041 | CID_5318041 | |
| 0.273 | 0.132 | 0.281 | Immunosuppressant | 0.281 0.127 CID_5318041 | CID_5318041 | |
| 0.145 | 0.006 | 0.152 | Estradiol 17 beta-dehydrogenase inhibitor | 0.152 0.006 CID_5318041 | CID_5318041 | |
| 0.192 | 0.06 | 0.241 | Mcl-1 antagonist | 0.241 0.039 CID_5318041 | CID_5318041 | |
| 0.229 | 0.102 | 0.229 | Transcription factor STAT3 inhibitor | 0.229 0.102 CID_5318041 | ||
| 0.178 | 0.052 | 0.187 | Interferon gamma antagonist | 0.187 0.046 CID_5318041 | CID_5318041 | |
| 0.145 | 0.024 | 0.145 | Calcium antagonist | 0.141 0.025 CID_5318041 | ||
| 0.134 | 0.014 | 0.135 | Myeloperoxidase inhibitor | 0.135 0.014 CID_5318041 | CID_5318041 | |
| 0.159 | 0.04 | 0.164 | Cholesterol synthesis inhibitor | 0.164 0.038 CID_5318041 | CID_5318041 | |
| 0.124 | 0.007 | 0.145 | Topoisomerase II beta inhibitor | 0.145 0.005 CID_5318041 | CID_5318041 | |
| 0.12 | 0.004 | 0.12 | GABA B receptor antagonist | 0.102 0.005 CID_5318041 | ||
| 0.154 | 0.04 | 0.169 | Protein kinase (CK2) alpha inhibitor | 0.169 0.033 CID_5318041 | CID_5318041 | |
| 0.136 | 0.022 | 0.136 | Thioredoxin inhibitor | 0.128 0.026 CID_5318041 | ||
| 0.129 | 0.017 | 0.156 | CDC25A inhibitor | 0.156 0.012 CID_5318041 | CID_5318041 | |
| 0.165 | 0.053 | 0.193 | Mannose-6-phosphate isomerase inhibitor | 0.193 0.034 CID_5318041 | CID_5318041 | |
| 0.164 | 0.052 | 0.178 | Cytokine production inhibitor | 0.178 0.044 CID_5318041 | CID_5318041 | |
| 0.191 | 0.083 | 0.198 | Insulin sensitizer | 0.198 0.075 CID_5318041 | CID_5318041 | |
| 0.128 | 0.02 | 0.13 | Ornithine decarboxylase inhibitor | 0.13 0.019 CID_5318041 | CID_5318041 | |
| 0.145 | 0.038 | 0.16 | Expectorant | 0.16 0.031 CID_5318041 | CID_5318041 | |
| 0.134 | 0.027 | 0.134 | Androgen antagonist | 0.13 0.029 CID_5318041 | ||
| 0.114 | 0.008 | 0.118 | Fatty acid synthase inhibitor | 0.118 0.007 CID_5318041 | CID_5318041 | |
| 0.19 | 0.085 | 0.194 | Histone acetyltransferase inhibitor | 0.194 0.078 CID_5318041 | CID_5318041 | |
| 0.123 | 0.021 | 0.123 | Keratolytic | 0.118 0.022 CID_5318041 | ||
| 0.111 | 0.01 | 0.111 | Estrogen receptor beta agonist | 0.068 0.016 CID_5318041 | ||
| 0.155 | 0.054 | 0.166 | Adenylate cyclase stimulant | 0.166 0.04 CID_5318041 | CID_5318041 | |
| 0.234 | 0.134 | 0.252 | Thyroid hormone antagonist | 0.252 0.122 CID_5318041 | CID_5318041 | |
| 0.118 | 0.019 | 0.118 | Lipase inhibitor | 0.118 0.019 CID_5318041 | ||
| 0.105 | 0.005 | 0.112 | Transcription factor RelA inhibitor | 0.112 0.004 CID_5318041 | CID_5318041 | |
| 0.134 | 0.035 | 0.134 | Antineoplastic antibiotic | 0.132 0.035 CID_5318041 | ||
| 0.166 | 0.068 | 0.166 | Neurotensin receptor agonist | 0.149 0.104 CID_5318041 | ||
| 0.128 | 0.03 | 0.144 | Phosphodiesterase IV inhibitor | 0.144 0.024 CID_5318041 | CID_5318041 | |
| 0.213 | 0.116 | 0.218 | 5 Hydroxytryptamine 1E antagonist | 0.218 0.111 CID_5318041 | CID_5318041 | |
| 0.209 | 0.115 | 0.209 | Immunostimulant | 0.185 0.13 CID_5318041 | ||
| 0.133 | 0.04 | 0.133 | Transcription factor STAT6 inhibitor | 0.127 0.049 CID_5318041 | ||
| 0.121 | 0.028 | 0.124 | Phosphodiesterase 4D inhibitor | 0.124 0.026 CID_5318041 | CID_5318041 | |
| 0.135 | 0.042 | 0.144 | Mucolytic | 0.144 0.036 CID_5318041 | CID_5318041 | |
| 0.227 | 0.133 | 0.244 | Thyroid hormone beta antagonist | 0.244 0.122 CID_5318041 | CID_5318041 | |
| 0.122 | 0.033 | 0.122 | Alcohol dehydrogenase inhibitor | 0.114 0.039 CID_5318041 | ||
| 0.126 | 0.038 | 0.126 | Toll-Like receptor 4 antagonist | 0.122 0.042 CID_5318041 | ||
| 0.097 | 0.009 | 0.097 | Estrogen receptor alpha agonist | 0.064 0.014 CID_5318041 | ||
| 0.103 | 0.015 | 0.103 | Neuraminidase (influenza) inhibitor | 0.101 0.016 CID_5318041 | ||
| 0.099 | 0.011 | 0.099 | Glutamate (mGluR7) antagonist | 0.091 0.016 CID_5318041 | ||
| 0.101 | 0.013 | 0.101 | Aryl hydrocarbon receptor antagonist | 0.091 0.018 CID_5318041 | ||
| 0.111 | 0.024 | 0.111 | Carbonic anhydrase V inhibitor | 0.104 0.026 CID_5318041 | ||
| 0.107 | 0.021 | 0.127 | HIV-1 integrase inhibitor | 0.127 0.013 CID_5318041 | CID_5318041 | |
| 0.141 | 0.055 | 0.141 | Antibacterial (Helicobacter pylori) | 0.139 0.057 CID_5318041 | ||
| 0.106 | 0.022 | 0.106 | Carbonic anhydrase VA inhibitor | 0.101 0.025 CID_5318041 | ||
| 0.16 | 0.077 | 0.16 | Heat shock protein 90 alpha antagonist | 0.147 0.09 CID_5318041 | ||
| 0.115 | 0.034 | 0.115 | Interleukin 12 antagonist | 0.092 0.067 CID_5318041 | ||
| 0.106 | 0.027 | 0.106 | mTOR complex 2 inhibitor | 0.106 0.027 CID_5318041 | ||
| 0.132 | 0.055 | 0.144 | Beta amyloid protein antagonist | 0.144 0.045 CID_5318041 | CID_5318041 | |
| 0.142 | 0.066 | 0.142 | Ca2+-transporting ATPase inhibitor | 0.138 0.082 CID_5318041 | ||
| 0.094 | 0.018 | 0.094 | Neuraminidase inhibitor | 0.094 0.018 CID_5318041 | ||
| 0.128 | 0.052 | 0.137 | Microtubule formation inhibitor | 0.137 0.045 CID_5318041 | CID_5318041 | |
| 0.172 | 0.097 | 0.172 | I kappa B kinase epsilon inhibitor | 0.169 0.1 CID_5318041 | ||
| 0.141 | 0.067 | 0.152 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.152 0.06 CID_5318041 | CID_5318041 | |
| 0.121 | 0.048 | 0.133 | Protein kinase (CK2) inhibitor | 0.133 0.041 CID_5318041 | CID_5318041 | |
| 0.101 | 0.029 | 0.101 | Glutamate decarboxylase inhibitor | 0.093 0.034 CID_5318041 | ||
| 0.08 | 0.009 | 0.086 | Ryanodine receptor antagonist | 0.086 0.006 CID_5318041 | CID_5318041 | |
| 0.086 | 0.019 | 0.086 | Protease activated receptor antagonist | 0.078 0.026 CID_5318041 | ||
| 0.086 | 0.021 | 0.086 | Protein kinase C eta inhibitor | 0.076 0.026 CID_5318041 | ||
| 0.075 | 0.01 | 0.078 | DNA-dependent protein kinase inhibitor | 0.078 0.009 CID_5318041 | CID_5318041 | |
| 0.085 | 0.022 | 0.085 | Alcohol oxidase inhibitor | 0.05 0.045 CID_5318041 | ||
| 0.11 | 0.049 | 0.11 | Sphingomyelinase inhibitor | 0.1 0.06 CID_5318041 | ||
| 0.069 | 0.009 | 0.08 | Dopamine D5 agonist | 0.08 0.006 CID_5318041 | CID_5318041 | |
| 0.081 | 0.022 | 0.081 | Beta 3 adrenoreceptor antagonist | 0.081 0.022 CID_5318041 | ||
| 0.076 | 0.018 | 0.081 | Carbonic anhydrase XIV inhibitor | 0.081 0.016 CID_5318041 | CID_5318041 | |
| 0.097 | 0.04 | 0.115 | Granulocyte macrophage colony stimulating factor agonist | 0.115 0.019 CID_5318041 | CID_5318041 | |
| 0.058 | 0.004 | 0.058 | Estrogen-related receptor beta antagonist | 0.049 0.005 CID_5318041 | ||
| 0.092 | 0.04 | 0.092 | CYP2A6 inhibitor | 0.068 0.061 CID_5318041 | ||
| 0.068 | 0.017 | 0.076 | Glucose-6-phosphate translocase inhibitor | 0.076 0.013 CID_5318041 | CID_5318041 | |
| 0.089 | 0.042 | 0.089 | Estrogen-related receptor beta agonist | 0.08 0.068 CID_5318041 | ||
| 0.089 | 0.042 | 0.089 | Na+ K+ transporting ATPase inhibitor | 0.086 0.045 CID_5318041 | ||
| 0.051 | 0.007 | 0.055 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.055 0.006 CID_5318041 | CID_5318041 | |
| 0.058 | 0.014 | 0.058 | Neuraminidase (Influenza A) inhibitor | 0.057 0.015 CID_5318041 | ||
| 0.056 | 0.013 | 0.056 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.048 0.017 CID_5318041 | ||
| 0.069 | 0.029 | 0.069 | Cyclin D1 inhibitor | 0.061 0.04 CID_5318041 | ||
| 0.081 | 0.042 | 0.081 | Adenosine A3 receptor antagonist | 0.07 0.059 CID_5318041 | ||
| 0.202 | 0.163 | 0.202 | Cholesterol antagonist | 0.198 0.166 CID_5318041 | ||
| 0.075 | 0.036 | 0.098 | Dopamine D1 antagonist | 0.098 0.026 CID_5318041 | CID_5318041 | |
| 0.06 | 0.021 | 0.065 | CD45 antagonist | 0.065 0.017 CID_5318041 | CID_5318041 | |
| 0.146 | 0.108 | 0.146 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.068 | 0.03 | 0.068 | Maillard reaction inhibitor | 0.067 0.03 CID_5318041 | ||
| 0.049 | 0.012 | 0.049 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.042 0.015 CID_5318041 | ||
| 0.099 | 0.063 | 0.099 | Cyclin-dependent kinase 9 inhibitor | 0.097 0.066 CID_5318041 | ||
| 0.061 | 0.031 | 0.061 | Cyclin B2 inhibitor | 0.057 0.036 CID_5318041 | ||
| 0.062 | 0.032 | 0.062 | Carbonic anhydrase XII inhibitor | 0.054 0.035 CID_5318041 | ||
| 0.088 | 0.059 | 0.088 | NADH dehydrogenase inhibitor | 0.087 0.061 CID_5318041 | ||
| 0.068 | 0.04 | 0.079 | CDC25B inhibitor | 0.079 0.029 CID_5318041 | CID_5318041 | |
| 0.062 | 0.034 | 0.062 | Carbonic anhydrase VB inhibitor | 0.058 0.037 CID_5318041 | ||
| 0.053 | 0.027 | 0.053 | Factor III inhibitor | 0.052 0.03 CID_5318041 | ||
| 0.198 | 0.172 | 0.233 | Angiogenesis inhibitor | 0.233 0.136 CID_5318041 | CID_5318041 | |
| 0.146 | 0.12 | 0.146 | Psychostimulant | 0.134 0.132 CID_5318041 | ||
| 0.144 | 0.118 | 0.144 | Phospholipase C inhibitor | 0.14 0.129 CID_5318041 | ||
| 0.068 | 0.042 | 0.072 | Leukotriene antagonist | 0.072 0.038 CID_5318041 | CID_5318041 | |
| 0.064 | 0.038 | 0.064 | Cyclin B1 inhibitor | 0.059 0.045 CID_5318041 | ||
| 0.099 | 0.074 | 0.106 | DNA intercalator | 0.106 0.067 CID_5318041 | CID_5318041 | |
| 0.064 | 0.039 | 0.065 | Phosphodiesterase 1C inhibitor | 0.065 0.037 CID_5318041 | CID_5318041 | |
| 0.038 | 0.015 | 0.038 | ATP citrate lysase inhibitor | 0.037 0.016 CID_5318041 | ||
| 0.103 | 0.081 | 0.103 | Acetylcholine release stimulant | |||
| 0.037 | 0.016 | 0.078 | Catechol O-methyltransferase inhibitor | 0.078 0.005 CID_5318041 | CID_5318041 | |
| 0.093 | 0.072 | 0.104 | Bronchodilator | 0.104 0.06 CID_5318041 | CID_5318041 | |
| 0.126 | 0.107 | 0.127 | Phospholipase A2 inhibitor | 0.127 0.105 CID_5318041 | CID_5318041 | |
| 0.078 | 0.061 | 0.078 | Opioid kappa receptor antagonist | |||
| 0.027 | 0.012 | 0.027 | Estrone sulfatase inhibitor | 0.027 0.011 CID_5318041 | ||
| 0.138 | 0.124 | 0.138 | ATPase inhibitor | 0.138 0.125 CID_5318041 | ||
| 0.089 | 0.075 | 0.089 | UDP-glucose 4-epimerase inhibitor | |||
| 0.125 | 0.111 | 0.125 | Hexokinase inhibitor | |||
| 0.063 | 0.05 | 0.063 | Beta adrenoreceptor antagonist | 0.063 0.049 CID_5318041 | ||
| 0.037 | 0.025 | 0.04 | Arginase inhibitor | 0.04 0.023 CID_5318041 | CID_5318041 | |
| 0.09 | 0.078 | 0.09 | Anabolic | 0.086 0.085 CID_5318041 | ||
| 0.062 | 0.052 | 0.074 | Leukotriene synthesis inhibitor | 0.074 0.041 CID_5318041 | CID_5318041 | |
| 0.033 | 0.023 | 0.034 | Protein kinase (CK2) beta inhibitor | 0.034 0.022 CID_5318041 | CID_5318041 | |
| 0.085 | 0.076 | 0.085 | Glutamate release inhibitor | |||
| 0.051 | 0.043 | 0.051 | GABA receptor antagonist | |||
| 0.024 | 0.016 | 0.024 | Dopamine autoreceptor agonist | |||
| 0.104 | 0.096 | 0.104 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.172 | 0.165 | 0.172 | DNA synthesis inhibitor | |||
| 0.051 | 0.044 | 0.051 | Cyclin B inhibitor | |||
| 0.075 | 0.07 | 0.077 | Glutathione S-transferase inhibitor | 0.077 0.065 CID_5318041 | CID_5318041 | |
| 0.235 | 0.23 | 0.254 | Cyclophilin D inhibitor | 0.254 0.208 CID_5318041 | CID_5318041 | |
| 0.096 | 0.092 | 0.096 | Proteasome inhibitor | |||
| 0.053 | 0.05 | 0.053 | Leukotriene C antagonist | |||
| 0.116 | 0.113 | 0.116 | Farnesoid X receptor antagonist | |||
| 0.029 | 0.027 | 0.029 | Estrogen-related receptor alpha antagonist | |||
| 0.018 | 0.016 | 0.018 | Antibiotic Anthracycline-like | |||
| 0.081 | 0.079 | 0.081 | Prolactin inhibitor | |||
| 0.079 | 0.078 | 0.08 | Phosphodiesterase I inhibitor | 0.08 0.078 CID_5318041 | CID_5318041 | |
| 0.021 | 0.02 | 0.032 | Dopamine D1 agonist | 0.032 0.008 CID_5318041 | CID_5318041 | |
| 0.048 | 0.049 | 0.05 | Leukotriene B4 antagonist | 0.05 0.044 CID_5318041 | CID_5318041 | |
| 0.06 | 0.063 | 0.065 | Elastase 1 inhibitor | 0.065 0.054 CID_5318041 | CID_5318041 | |
| 0.079 | 0.089 | 0.091 | Alpha 2c adrenoreceptor antagonist | 0.091 0.074 CID_5318041 | CID_5318041 | |
| 0.076 | 0.085 | 0.093 | HIV-1 integrase (Overall Integration) inhibitor | 0.093 0.062 CID_5318041 | CID_5318041 | |
| 0.048 | 0.065 | 0.08 | Dopamine agonist | 0.08 0.037 CID_5318041 | CID_5318041 | |
| 0.024 | 0.042 | 0.031 | Melatonin 2 agonist | 0.031 0.025 CID_5318041 | CID_5318041 | |
| 0.137 | 0.159 | 0.148 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.148 0.135 CID_5318041 | CID_5318041 | |
| 0.027 | 0.049 | 0.042 | Dopamine D5 antagonist | 0.042 0.031 CID_5318041 | CID_5318041 | |
| 0.228 | 0.262 | 0.268 | MAP kinase 1 inhibitor | 0.268 0.214 CID_5318041 | CID_5318041 | |
| 0.117 | 0.205 | 0.138 | Death-associated protein kinase 2 inhibitor | 0.138 0.136 CID_5318041 | CID_5318041 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |